Christopher A. Viehbacher

Vice Chairman, CEO Roundtable on Cancer
Chief Executive Officer, sanofi-aventis

Photo2008_Chris 001.JPGChristopher A. Viehbacher, born March 26, 1960, holds German and Canadian nationalities. He is a graduate of the Queens University (Ontario – Canada) and a certified public accountant.

After beginning his career at PriceWaterhouseCoopers, between 1988-2008 he acquired broad international experience in Europe, in the United States and in Canada with the GlaxoSmithKline (GSK) Company. In his last position, Mr. Viehbacher was President, Pharmaceutical Operations North America, a member of the board and Co-Chairman of the Portfolio Management Board.

As from December 1, 2008, Mr. Viehbacher is a sanofi-aventis board member, CEO and a member of the Strategy Committee.

Mr. Viehbacher is a Board member of PhRMA in the United States and serves as Vice Chairman of the CEO Roundtable on Cancer.

Mr. Viehbacher is married with three children. He speaks French, English and German. He lived in France for nine years and was made a knight of the French Legion of Honor in 2003.

 

October 10 2008
CEO Roundtable on Cancer Offers “Common Language” to Jump Start Cancer Clinical Trials
- Partnership with National Cancer Institute, academic centers and industry could speed new therapies to cancer patients -
Read More

Standard Terms of Agreement for Research Trial (START) Clauses

StartCover.png Access to standardized legal language for Key elements can increase the efficiency of contract negotiations, resulting in reduced costs and accelerating the entry of new therapies into clinical trials.

Print Page Email Page to Friend Feedback
© 2010 by Life Sciences Consortium  All rights reserved.